Collegium Pharmaceutical Inc (NASDAQ: COLL) stock enjoyed a major increase of 14.4% on 1/8/25. The shares closed at $33.34. Moreover, this advance was accompanied by exceptionally high trading volume at 248% of normal. The stock has been weak relative to the market over the last nine months but has risen 16.5% during the last week.
Current PriceTarget Research Rating
Collegium Pharmaceutical has a current Value Trend Rating of C (High Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Collegium Pharmaceutical has a very high Appreciation Score of 95 but a slightly negative Power Rating of 32, triggering the High Neutral Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment